Search Results - "Coppola, N"

Refine Results
  1. 1

    Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients by Marfella, R., Paolisso, P., Sardu, C., Bergamaschi, L., D’Angelo, E.C., Barbieri, M., Rizzo, M.R., Messina, V., Maggi, P., Coppola, N., Pizzi, C., Biffi, M., Viale, P., Galié, N., Paolisso, G.

    Published in Diabetes & metabolism (01-10-2020)
    “…Tocilizumab (TCZ) is used for treating moderate-to-severe Covid-19 pneumonia by targeting interleukin-6 receptors (IL-6Rs) and reducing cytokine release. Yet,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A by Gentile, I, Borgia, F, Coppola, N, Buonomo, A R, Castaldo, G, Borgia, G

    Published in Current medicinal chemistry (01-04-2014)
    “…Hepatitis C virus (HCV) infection affects about 160 million people worldwide. It is treated with pegylatedinterferon (peg-IFN) and ribavirin, and in the case…”
    Get more information
    Journal Article
  5. 5

    Preexisting mild cognitive impairment as a risk factor for COVID-19 infection: A scoping review and case reports by Catapano, P., Messina, M., Russo, A., Tucci, C., Luciano, M., De Santis, V., Perris, F., Catapano, F., Coppola, N., Fabrazzo, M.

    Published in European psychiatry (01-06-2022)
    “…Introduction SARS-Co-V2 neuroinvasive ability might be the basis for the onset of delirium and neuropsychiatric outcomes. Objectives We hypothesized that some…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The music-related quality of life: Italian validation of MuRQoL into MUSQUAV questionnaire and preliminary data from a cohort of postlingually deafened cochlear implant users by Frosolini, A., Parrino, D., Mancuso, A., Coppola, N., Genovese, E., de Filippis, C.

    Published in European archives of oto-rhino-laryngology (01-10-2022)
    “…Purpose Cochlear implant (CI) users do not receive much of the auditory information necessary for an accurate perception of music. This usually entails a…”
    Get full text
    Journal Article
  8. 8

    The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis by Onorato, L., Macera, M., Calò, F., Monari, C., Russo, F., Iovene, M.R., Signoriello, G., Annibale, R., Pace, M.C., Aurilio, C., Gaeta, G.B., Coppola, N.

    Published in Clinical microbiology and infection (01-06-2020)
    “…To evaluate the effect of an antimicrobial stewardship programme in two intensive care units (ICUs) of a teaching hospital. Between January 2017 and June 2018…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response by Niro, G. A., Smedile, A., Fontana, R., Olivero, A., Ciancio, A., Valvano, M. R., Pittaluga, F., Coppola, N., Wedemeyer, H., Zachou, K., Marrone, A., Fasano, M., Lotti, G., Andreone, P., Iacobellis, A., Andriulli, A., Rizzetto, M.

    Published in Alimentary pharmacology & therapeutics (01-09-2016)
    “…Summary Background Therapy of chronic hepatitis D with Interferon is successful when testing for HDV‐RNA turns negative. This end‐point is disputed. Aim To…”
    Get full text
    Journal Article
  14. 14

    Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection by Coppola, N., Marrone, A., Pisaturo, M., Starace, M., Signoriello, G., Gentile, I., Adinolfi, L. E., Sagnelli, E., Zampino, R.

    “…The purpose of this investigation was to evaluate the role of IL28-B polymorphism in the clearance of hepatitis C virus (HCV) in chronic hepatitis B virus…”
    Get full text
    Journal Article
  15. 15

    Correction to: Occult HBV infection in the oncohematological setting by Sagnelli, C., Macera, M., Pisaturo, M., Zampino, R., Coppola, N., Sagnelli, E.

    Published in Infection (01-08-2020)
    “…The original version of this article unfortunately contained a mistake…”
    Get full text
    Journal Article
  16. 16

    Clinical characterization of gingival type of burning mouth syndrome: a cross-sectional study by Coppola, N., Blasi, A., Amato, M., Ferrigno, R., Mignogna, MD, Leuci, S.

    “…BACKGROUNDThe aim of this study is to investigate the prevalence of localized intraoral neuropathic pain in a cluster of patients who reported the involvement…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Virological patterns of hepatitis C virus patients with failure to the current-generation direct-acting antivirals by Pisaturo, M., Starace, M., Minichini, C., De Pascalis, S., Occhiello, L., Fraia, A. Di, Messina, V., Sangiovanni, V., Claar, E., Coppola, N.

    “…•Few data on virological characterisation of patients with failure to current-generation direct-acting antivirals (DAAs).•Prevalence of resistance-associated…”
    Get full text
    Journal Article
  19. 19

    Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C by Zampino, R., Coppola, N., Cirillo, G., Boemio, A., Pisaturo, M., Marrone, A., Macera, M., Sagnelli, E., Perrone, L., Adinolfi, L. E., Miraglia del Giudice, E.

    Published in Journal of viral hepatitis (01-08-2013)
    “…Summary The patatin‐like phospholipase domain‐containing 3 gene (PNPLA3) and the apolipoprotein C3 gene (APOC3) have been studied in relation to liver…”
    Get full text
    Journal Article
  20. 20